Moderate Evidence

Promising research with growing clinical support from multiple studies

Holistic Treatment for High Cholesterol

High cholesterol—more precisely, dyslipidemia—refers to unfavorable levels of LDL (“bad”) cholesterol, HDL (“good”) cholesterol, and triglycerides that increase the risk of atherosclerotic cardiovascular disease (ASCVD), including heart attack and stroke. A holistic view looks at both risk reduction from proven biomedical therapies and the broader lifestyle, dietary, and mind–body factors emphasized in Eastern traditions. Comparing these perspectives helps people understand what reliably lowers events, what may support lipid balance, and how to coordinate care safely. From a Western standpoint, LDL is a primary driver of plaque formation in arteries. Standard care assesses a fasting or nonfasting lipid panel, screens for secondary causes (thyroid, kidney, liver, medications), and uses global risk calculators to estimate 10-year ASCVD risk. Evidence is strongest for statins, which lower LDL and reduce heart attacks, strokes, and cardiovascular mortality across many populations. For those who need more LDL lowering or cannot take statins, ezetimibe and PCSK9 inhibitors further reduce LDL; clinical trials show additional event reduction when these are added to statins in higher-risk groups. Lifestyle measures—nutrient-dense dietary patterns (e.g., Mediterranean-style), weight management, regular physical activity, and avoidance of tobacco—support lipid improvements and overall risk reduction. Western medicine is clear on expected outcomes: the greater and more sustained the LDL reduction, the larger the reduction in cardiovascular events. Limitations include statin-associated muscle symptoms in a minority of people, small risks like new-onset diabetes in predisposed individuals, and access/cost issues for newer agents. Eastern systems conceptualize dyslipidemia through functional patterns rather than isolated numbers. In Traditional Chinese Medicine (TCM), high lipids are often framed as “phlegm-dampness,” stagnation of Liver Qi, and “blood stasis.” Treatment aims to

cardiovascular Updated March 17, 2026

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.

Western Medicine

Diagnosis

Diagnosis uses a lipid panel (total cholesterol, LDL-C, HDL-C, triglycerides), often nonfasting; confirmation or secondary-cause evaluation may include repeat fasting lipids, thyroid-stimulating hormone, liver and kidney function, and evaluation for familial hypercholesterolemia when LDL is very high or there is early ASCVD. Global ASCVD risk is estimated with pooled cohort equations to guide intensity of therapy and expected percent LDL reduction.

Treatments

  • Lifestyle interventions: Mediterranean-style eating patterns emphasizing vegetables, fruits, legumes, whole grains, nuts, and olive oil; limiting saturated fats and eliminating trans fats; increased soluble fiber; weight management; regular aerobic and resistance activity; reduced alcohol for high triglycerides; smoking cessation
  • Risk-based pharmacotherapy to achieve percent LDL-C reduction targets (e.g., high-intensity lowering for higher risk)
  • Management of secondary causes (e.g., hypothyroidism, nephrotic syndrome, medications)
  • Referral for genetic counseling or lipid specialist care in suspected familial hypercholesterolemia

Medications

  • Statins: atorvastatin, rosuvastatin, simvastatin, pravastatin
  • Cholesterol absorption inhibitor: ezetimibe
  • PCSK9 pathway therapies: alirocumab, evolocumab; small interfering RNA: inclisiran (LDL lowering; cardiovascular outcomes data in progress)
  • Adenosine triphosphate-citrate lyase inhibitor: bempedoic acid (event reduction shown in statin-intolerant populations)
  • Bile acid sequestrants: cholestyramine, colesevelam, colestipol
  • Triglyceride-lowering agents in hypertriglyceridemia: fenofibrate, gemfibrozil; omega-3 therapies including icosapent ethyl (event reduction in high-risk, high-triglyceride adults on statins)
  • Niacin (limited role due to lack of added outcome benefit and side effects)

Limitations

Statin-associated muscle symptoms occur in a subset and may affect adherence; rare rhabdomyolysis and hepatotoxicity; small increase in diabetes risk among predisposed individuals; injection-site reactions and high cost for PCSK9 inhibitors; variable adherence to lifestyle changes; disparities in access; some agents lack long-term outcomes data in all populations (e.g., inclisiran).

Evidence: Strong Evidence

Sources

  • 2018/2019 ACC/AHA Cholesterol Guidelines outline risk-stratified LDL lowering and use of statins, ezetimibe, and PCSK9 inhibitors
  • A 2022 USPSTF recommendation statement supports statins for primary prevention in appropriate risk groups
  • The IMPROVE-IT trial (NEJM 2015) showed ezetimibe added to statin reduced events
  • PCSK9 inhibitor trials (FOURIER 2017; ODYSSEY OUTCOMES 2018) showed further event reduction with large LDL lowering
  • CLEAR Outcomes (NEJM 2023) found bempedoic acid reduced cardiovascular events in statin-intolerant patients
  • REDUCE-IT (NEJM 2019) showed icosapent ethyl reduced events in high-risk patients with elevated triglycerides on statins
  • Cochrane reviews (latest updates) consistently show statins reduce all-cause and cardiovascular mortality

Eastern & Traditional Medicine

Traditional Chinese Medicine (TCM)

Dyslipidemia is often viewed as phlegm-damp accumulation with Liver Qi stagnation and blood stasis. Goals are to transform phlegm, move Liver Qi, invigorate blood, and support Spleen (digestive) function to harmonize metabolism.

Techniques

  • Acupuncture protocols tailored to pattern differentiation; commonly used points may include ST36, SP6, ST40 (phlegm), LR3, PC6, and SP9
  • Herbal formulas individualized by pattern: examples include Er Chen Tang (phlegm-damp), Xue Fu Zhu Yu Tang (blood stasis), and additions such as Shan Zha (Crataegus/hawthorn), Jue Ming Zi (Cassia), and Dan Shen (Salvia)
  • Dietary energetics to reduce dampness (lighter, less greasy foods), mindful eating, and gentle movement practices like tai chi or qigong
Licensed acupuncturists TCM herbalists Oriental medicine doctors (DAOM/OMD)
Evidence: Emerging Research

Ayurveda

High cholesterol is related to Medo Dhatu (adipose/metabolic tissue) imbalance and aggravated Kapha with accumulation of Ama (metabolic residues). Treatment seeks to kindle Agni (digestive fire), reduce Ama, and balance Doshas through herbs, diet, and lifestyle.

Techniques

  • Herbs traditionally used for lipid balance: Guggul (Commiphora mukul), Triphala, Arjuna (Terminalia arjuna), and garlic (Lasuna)
  • Dietary guidance favoring lighter, warming, Kapha-pacifying foods; spices to support digestion
  • Yoga, pranayama, and stress-reduction; Panchakarma detoxification protocols in selected cases
Ayurvedic physicians (BAMS/MD Ayurveda) Ayurvedic practitioners and counselors
Evidence: Emerging Research

Naturopathic/Functional Nutrition

Focuses on diet quality, fiber, plant sterols/stanols, weight management, insulin sensitivity, gut–liver axis, and stress. Emphasizes whole-food patterns alongside targeted nutraceuticals when appropriate.

Techniques

  • Dietary patterns: Mediterranean-style, increased soluble fiber (oats, legumes), nuts, and olive oil; reduced refined carbohydrates for high triglycerides
  • Plant sterols/stanols and viscous fibers (e.g., psyllium) to lower LDL absorption and reabsorption
  • Nutraceuticals: berberine (lipid and glycemic effects), omega-3s for triglycerides; careful selection and monitoring for quality and interactions
  • Behavioral and mind–body practices to support adherence and stress resilience
Registered dietitians Naturopathic doctors (ND) Integrative/functional medicine clinicians
Evidence: Moderate Evidence

Sources

  • A 2019 systematic review of acupuncture for dyslipidemia reported small reductions in total cholesterol and triglycerides with low to very low certainty due to heterogeneity
  • Observational and small randomized studies suggest TCM herbal combinations may modestly improve lipid profiles, but standardized formulas and high-quality trials are limited
  • A large randomized Chinese trial of red yeast rice extract (Xuezhikang) showed reduced cardiovascular events in secondary prevention, though product standardization differs globally
  • Classical texts (Charaka Samhita, Sushruta Samhita) describe Medoroga and Kapha-related metabolic imbalance
  • Systematic reviews show mixed, modest lipid-lowering effects of Guggul and Triphala with variable quality and standardization
  • Meta-analyses of garlic suggest small LDL and total cholesterol reductions; event data are lacking
  • A 2020 meta-analysis found plant sterols/stanols lower LDL by roughly 7–12% depending on dose and matrix
  • Systematic reviews show soluble fiber (e.g., psyllium, beta-glucan) produces modest LDL reductions
  • Meta-analyses suggest berberine modestly lowers LDL, triglycerides, and improves glycemia; quality and standardization vary
  • Mediterranean diet trials (e.g., PREDIMED) show reduced cardiovascular events with an overall dietary pattern

Integrative Perspective

Integrative care often combines the event-proven benefits of statins (and other lipid-lowering drugs when needed) with lifestyle, nutrition, and selected Eastern practices. Practical models include: Western risk stratification to set LDL-C reduction goals; Mediterranean-style eating enhanced with soluble fiber and, when appropriate, plant sterols/stanols; and mind–body approaches (yoga, tai chi, acupuncture) to help with stress, sleep, and adherence. Some individuals explore TCM or Ayurvedic herbs under professional guidance. Safety is central. Red yeast rice contains monacolin K (a lovastatin analogue); combining it with prescription statins may increase risk of muscle or liver side effects, and product potency varies widely. Guggul may interact with anticoagulants, thyroid medications, and certain liver-metabolized drugs. Berberine can inhibit CYP3A4 and P-gp and may interact with many medicines, including cyclosporine and some statins. He Shou Wu (Polygonum multiflorum) has been associated with liver injury. Quality-controlled products, medication reconciliation, and shared lab monitoring (lipid panels, liver enzymes when indicated) are important. Research on combined East–West protocols is limited, but lifestyle and mind–body practices are generally compatible with pharmacotherapy and may improve overall cardiometabolic health. Coordinate care by informing all practitioners about medications and supplements, agreeing on targets and timelines, and scheduling follow-up to review response and safety.

Sources

  1. ACC/AHA Cholesterol Guidelines (2018/2019) for risk-based LDL lowering
  2. USPSTF 2022 statin recommendation for primary prevention
  3. IMPROVE-IT (NEJM 2015): ezetimibe added to statin reduced cardiovascular events
  4. FOURIER (2017) and ODYSSEY OUTCOMES (2018): PCSK9 inhibitors lowered events
  5. CLEAR Outcomes (NEJM 2023): bempedoic acid reduced events in statin-intolerant patients
  6. REDUCE-IT (NEJM 2019): icosapent ethyl reduced events in high-risk patients with elevated triglycerides
  7. PREDIMED trial: Mediterranean diet reduced cardiovascular events
  8. Systematic reviews of acupuncture, TCM herbs, and Ayurvedic botanicals show modest lipid effects with variable quality; robust event data are limited aside from standardized red yeast rice extract studies in China
  9. FDA advisories note variability and regulatory issues for red yeast rice supplements

Related Content

comparisons

High Cholesterol (Hyperlipidemia) — Western and Eastern Perspectives: East vs West

High Cholesterol (Hyperlipidemia) — Western and Eastern Perspectives. High cholesterol (hyperlipidemia) refers to elevated levels of lipids—primarily LDL cholesterol and triglycerides—in the blood. Persistently high LDL contributes to atherosclerotic plaque formation, raising the risk of heart attack and stroke. Western medicine frames this as a modifiable cardiovascu

comparisons

High Cholesterol — Herbal and Integrative Approaches: East vs West

High Cholesterol — Herbal and Integrative Approaches. High cholesterol (hypercholesterolemia) refers to unhealthy patterns of blood lipids—primarily elevated low-density lipoprotein cholesterol (LDL-C), sometimes high triglycerides, and often low high-density lipoprotein (HDL-C). Clinically, LDL-C is the main driver of atherosclerotic cardiovascular di

comparisons

Natural Remedies for High Cholesterol: East vs West

Natural Remedies for High Cholesterol. High cholesterol is a modifiable risk factor for atherosclerosis and cardiovascular disease. In Western medicine, the biology centers on lipoproteins: low-density lipoprotein cholesterol (LDL‑C) carries cholesterol into artery walls and is a major target for risk reduction, while high-density lipopr

relationships

High Cholesterol (Hypercholesterolemia) and Statins (HMG‑CoA Reductase Inhibitors)

High Cholesterol (Hypercholesterolemia) and Statins (HMG‑CoA Reductase Inhibitors). High cholesterol—especially elevated low-density lipoprotein cholesterol (LDL-C)—is a major driver of atherosclerosis, the process that leads to plaque buildup in arteries and, ultimately, heart attacks and strokes. LDL-C and other apolipoprotein B–containing particles carry cholesterol into the art

comparisons

Coronary Artery Disease — Herbal Remedies (West vs East): East vs West

Coronary Artery Disease — Herbal Remedies (West vs East). Coronary artery disease (CAD) arises when atherosclerotic plaque narrows or blocks the coronary arteries, reducing blood flow to the heart muscle. The biomedical goals of care are clear: prevent heart attacks and strokes, reduce symptoms like angina, and extend healthy life through risk-factor contr

comparisons

Natural Remedies for Obesity — West vs East: East vs West

Natural Remedies for Obesity — West vs East. Obesity is a chronic, relapsing condition shaped by biology, behavior, and environment. Western medicine typically defines it by body mass index (BMI ≥30 kg/m² for adults), waist circumference, and body composition, alongside metabolic markers such as fasting glucose, HbA1c, lipid profile, blood pre

Health Disclaimer

This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication regimen.